Klotho-regulated serine (RELA) phosphorylation can negatively regulate the production of NF-κB-linked inflammatory proteins and upregulate the cAMP/PKA pathway, which suppressing inflammation and improving insulin sensitivity, significantly regulating type I and type II diabetes [13,14]. This evidence concerns the gene PROS1 and type 2 diabetes mellitus.